Pharma News2025-01-21T17:40:39+01:00

Welcome to
our Blog

Here you can learn about the latest biometric developments for your sector

We inform you that the entity responsible for your personal data is VERAZIAL LABS SL, and your data will be processed for the purpose of managing and processing your request, as well as receiving commercial communications about updates, products, and services, based on your consent. The collected personal data will be shared, when necessary, for the development, fulfillment, and control of the requested or contracted services and as legally required. You may exercise your data protection rights by contacting .
 

Welcome to
our Blog

Here you can learn about the latest biometric developments for your sector

We inform you that the entity responsible for your personal data is VERAZIAL LABS SL, and your data will be processed for the purpose of managing and processing your request, as well as receiving commercial communications about updates, products, and services, based on your consent. The collected personal data will be shared, when necessary, for the development, fulfillment, and control of the requested or contracted services and as legally required. You may exercise your data protection rights by contacting .
 

Welcome to
our Blog

Here you can learn about the latest biometric developments for your sector

We inform you that the entity responsible for your personal data is VERAZIAL LABS SL, and your data will be processed for the purpose of managing and processing your request, as well as receiving commercial communications about updates, products, and services, based on your consent. The collected personal data will be shared, when necessary, for the development, fulfillment, and control of the requested or contracted services and as legally required. You may exercise your data protection rights by contacting .

Challenges of using RFID cards in the pharmaceutical industry

12/21/2023|

RFID cards provide some advantages when used for access control and as an electronic signature for employees in pharmaceutical production processes. However, they present a series of inconveniences that make the regulations themselves not accept them as the exclusive method of identification.

What are the disadvantages of using handwritten signatures in pharmaceutical process control?

12/14/2023|

In many pharmaceutical companies, employees record their manufacturing actions on paper with handwritten signatures, which creates risks and inefficiencies. It is possible to digitize these processes in a simple way and add the security of the biometric electronic signature.

Challenges in the control of pharmaceutical manufacturing processes on paper

12/07/2023|

In many pharmaceutical companies, employees still record manufacturing control data on paper and authenticate it with their handwritten signature. This can lead to inefficiencies and errors that jeopardize data integrity.

Problems using login and password as electronic signature in pharmaceutical manufacturing

11/13/2023|

The use of the biometric electronic signature not only ensures data integrity and compliance with pharmaceutical regulations, but also solves the problems of inconvenience and loss of time and efficiency of employees.

Electronic signature in pharmaceutical manufacturing: Does it preserve data integrity and comply with regulations?

11/06/2023|

Password-based electronic signatures are widely used in manufacturing software (MES, ERP) in the pharmaceutical industry, putting at risk data integrity and regulatory compliance. The solution is the biometric electronic signature.

Employees’ identification in the pharmaceutical industry according ALCOA+

10/30/2023|

The ALCOA+ requirements defined by the FDA establish, among others, the characteristics for correct identification of employees in regulated pharmaceutical processes. The use of biometrics solves the current difficulties in meeting them.

Subscribe to our newsletter

Receive information of interest about biometrics for your sector

We inform you that the entity responsible for your personal data is VERAZIAL LABS SL, and your data will be processed for the purpose of managing and processing your request, as well as receiving commercial communications about updates, products, and services, based on your consent. The collected personal data will be shared, when necessary, for the development, fulfillment, and control of the requested or contracted services and as legally required. You may exercise your data protection rights by contacting .
 

Subscribe to our newsletter

Receive information of interest about biometrics for your sector

We inform you that the entity responsible for your personal data is VERAZIAL LABS SL, and your data will be processed for the purpose of managing and processing your request, as well as receiving commercial communications about updates, products, and services, based on your consent. The collected personal data will be shared, when necessary, for the development, fulfillment, and control of the requested or contracted services and as legally required. You may exercise your data protection rights by contacting .
 

Subscribe to our newsletter

Receive information of interest about biometrics for your sector

We inform you that the entity responsible for your personal data is VERAZIAL LABS SL, and your data will be processed for the purpose of managing and processing your request, as well as receiving commercial communications about updates, products, and services, based on your consent. The collected personal data will be shared, when necessary, for the development, fulfillment, and control of the requested or contracted services and as legally required. You may exercise your data protection rights by contacting .

Go to Top